A Study in Non Small Cell Lung Cancer

NCT01139775 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: LY2603618

Sponsor

Eli Lilly and Company